$ABT feels like a quiet under-the-radar play right now. Strong exposure to pharma and emerging markets looks solid long term, but weaker segments like nutrition seem to be dragging sentiment. With the stock still well below highs, is this just temporary pressure or a real concern? Curious how others are viewing the risk vs upside here.